An industry has grown up around sleep apnea, stirring concerns about overdiagnosis and overtreatment.
Like others in academia or government who’ve served as public health advisers during the pandemic, Dr. Michael Mina traded his university role for a commercial venture. He recently took a top job at eMed, a startup that charges a premium price for monitoring at-home covid tests. Can experts do well by trying to do good?
The insurance company said that the birth of the Bull family’s twins was not an emergency and that NICU care was “not medically necessary.” The family’s experience with a huge bill sent to collections happened in 2020, but it exposes a hole in the new No Surprises law that took effect Jan. 1.
Legislative crackdowns on out-of-network bills haven’t kept specialists from hitting patients with unexpected charges running into thousands of dollars.
Regular use of a more advanced screening method turns a low-cost procedure into a pricier one.
Patients are caught in the middle as insurers clamp down on paying for treatments or force prior authorizations for care.
Pharmaceutical companies routinely cover the cost of patient copays for expensive drugs under private insurance. A federal judge could make the practice legal for millions on Medicare as well.
Only severely injured patients are supposed to be billed for “trauma team alert” fees that can exceed $50,000.
HCA charges patients an “activation fee” of up to $50,000 for trauma teams at centers located in half its 179 hospitals — and they often don’t need trauma care, an analysis of insurance claims data shows.
Because there are no caps on cost, consumers and insurers often get billed hundreds of dollars for the most reliable PCR covid test. Prices are rising and they can’t fight back.
The Virginia hospital giant had already stopped suing patients with less than $107,000 in household income.
Authorities seized 1.7 million fake masks in New York and U.S. Sen. Maria Cantwell called for a national probe.
Miles de estadounidenses están muriendo a causa de covid-19, pero los esfuerzos para aumentar la producción de vacunas que potencialmente salvan vidas están en un callejón sin salida.
Even invoking the widely heralded Defense Production Act to pressure drugmakers wouldn’t overcome vast obstacles.
After missteps in Washington, each state and county is left to juggle where to send vaccines first and how to get them to each nursing home, hospital local health department and even school.
The University of Virginia promised reforms but has stopped short of announcing them, while hospital giant VCU Health has freed tens of thousands from property liens.
Revirtiendo una tendencia en las contribuciones de las farmacéuticas, que enviaban mucho dinero a los republicanos, en lo que va de 2020 la industria se ha inclinado hacia los demócratas.
President Donald Trump has been heralding drugmakers as “great companies.” Yet in the final stretch of the presidential campaign, Trump is not feeling the love in pharma contributions. Former Vice President Joe Biden is, even though his proposed policies could dent the industry’s profitability.
Dozens of protesters were injured in recent protests, triggering efforts to limit or ban the use of rubber bullets and other projectiles.
Advocates of cheap and widely available vaccines thought the pandemic might change business as usual. They were wrong.